0001567619-21-001460.txt : 20210125 0001567619-21-001460.hdr.sgml : 20210125 20210125171733 ACCESSION NUMBER: 0001567619-21-001460 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200119 FILED AS OF DATE: 20210125 DATE AS OF CHANGE: 20210125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Arnold Mitchell CENTRAL INDEX KEY: 0001841497 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39752 FILM NUMBER: 21550762 MAIL ADDRESS: STREET 1: 200 ROUTE 9 NORTH STREET 2: SUITE 500 CITY: MANALAPAN STATE: NJ ZIP: 07726 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Petros Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001815903 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851410058 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5301 WISCONSIN AVENUE NW STREET 2: SUITE 570 CITY: WASHINGTON STATE: DC ZIP: 20015 BUSINESS PHONE: 301-215-7440 MAIL ADDRESS: STREET 1: 5301 WISCONSIN AVENUE NW STREET 2: SUITE 570 CITY: WASHINGTON STATE: DC ZIP: 20015 3 1 doc1.xml FORM 3 X0206 3 2020-01-19 0 0001815903 Petros Pharmaceuticals, Inc. PTPI 0001841497 Arnold Mitchell 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 0 1 0 0 Prin. Acct. Off/Prin. Fin. Off Common Stock, par value $0.0001 per share 779 D Common Stock, par value $0.0001 per share 390 I See Footnote The shares of common stock of Petros Pharmaceuticals, Inc. are directly held by Metuchen Therapeutics, LLC ("MT"). The Reporting Person holds an ownership percentage of 0.1% of MT. /s/ Mitchell Arnold 2021-01-25